Baird Starts Medpace (MEDP) at Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/10/2026
- Wall St slightly higher as SK Hynix's stellar debut limits losses in chip stocks
- Oil prices fall on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- S&P Downgrades Oracle To 'bbb-/A-3'; Outlook Stable
- The real reason Meta shares are surging has nothing to do with its new AI model
William Blair Starts Medpace (MEDP) at Outperform
September 6, 2016 8:02 AM EDTWilliam Blair initiated coverage on Medpace (NASDAQ: MEDP) with an Outperform rating.
For an analyst ratings summary and ratings history on Medpace click here. For more ratings news on Medpace click here.
Shares of Medpace closed at $30.70 yesterday.
... MoreCredit Suisse Starts Medpace (MEDP) at Outperform
September 6, 2016 7:08 AM EDTCredit Suisse initiates coverage on Medpace (NASDAQ: MEDP) with a Outperform rating and a price target of $35.00.
Analyst Erin Wilson commented, "MEDP is a leading global clinical stage contract research organization (CRO), differentiated in its exclusively full-service model. It should benefit from a... More
Wells Fargo Starts Medpace (MEDP) at Outperform
September 6, 2016 6:55 AM EDTWells Fargo initiated coverage on Medpace (NASDAQ: MEDP) with an Outperform rating.
For an analyst ratings summary and ratings history on Medpace click here. For more ratings news on Medpace click here.
Shares of Medpace closed at $30.70 yesterday.
... MoreJefferies Starts Medpace (MEDP) at Hold
September 6, 2016 6:46 AM EDTJefferies initiates coverage on Medpace (NASDAQ: MEDP) with a Hold rating and a price target of $32.50.
Analyst David Windley commented, "We initiate on MEDP with a $32.50 PT and Hold rating on valuation (+33.5% since pricing). MEDP competes in the phase I-IV CRO space, wins mandates... More
UBS Starts Medpace (MEDP) at Buy
September 6, 2016 6:42 AM EDTUBS initiated coverage on Medpace (NASDAQ: MEDP) with a Buy rating and a price target of $35.00.
For an analyst ratings summary and ratings history on Medpace click here. For more ratings news on Medpace click here.
Shares of Medpace closed at $30.70 yesterday.
... More